Literature DB >> 8496155

Structure-function studies of the human thyrotropin receptor. Inhibition of binding of labeled thyrotropin (TSH) by synthetic human TSH receptor peptides.

J C Morris1, E R Bergert, D J McCormick.   

Abstract

We have probed the hormone binding regions of the entire putative extracellular domain of the human thyrotropin (TSH) receptor (hTSHr) using synthetic peptides. A series of 26 overlapping peptides comprising the complete sequence of the extracellular domain of hTSHr was synthesized. Each peptide (20 amino acid residues each) was tested for its ability to interact with TSH, as evidenced by inhibition of binding of labeled hormone to native, membrane bound TSH receptors. Four of the 26 peptides interacted with labeled TSH and inhibited its binding to thyroid membranes. The most potent of these peptides was 256-275, which inhibited 125I-bovine TSH binding with an IC50 of 31.7 +/- 1.3 microM. The remaining peptides were 16-35 (351 +/- 9.4 microM), 106-125 (282 +/- 20.5 microM), and 226-245 (951 +/- 245 microM). An additional peptide, 286-305, showed minimal activity, and the remaining 21 peptides showed no activity. Peptides 256-275, 106-125, and 16-35 also inhibited binding of 125I-human chorionic gonadotropin to ovarian membrane receptors, suggesting that those regions of the receptor are involved in binding of a common glycoprotein hormone structure such as the alpha-subunit. In contrast, peptides 226-245 and 286-305 did not inhibit human chorionic gonadotropin binding, suggesting that these two regions are involved in hormone-specific activity. Of interest is the finding that the latter two peptides are from regions of TSHr that are largely dis-homologous to the lutropin receptor, whereas the former three, with the exception of 16-35, are from regions that are largely homologous between the two receptors. The data suggest that multiple, discontinuous regions of the extracellular domain of hTSHr are involved in the binding of the hormone. Furthermore, the binding regions are localized to TSHr-specific sequences as well as to regions that are highly homologous to LHr. This suggests that homologous regions of the two receptors are likely to perform similar functions in the interaction with their specific hormone, suggesting that those regions may be involved in binding of the glycoprotein hormone common alpha-subunit.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8496155

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  A monoclonal thyroid-stimulating antibody.

Authors:  Takao Ando; Rauf Latif; Alla Pritsker; Thomas Moran; Yuji Nagayama; Terry F Davies
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Studies in mice deficient for the autoimmune regulator (Aire) and transgenic for the thyrotropin receptor reveal a role for Aire in tolerance for thyroid autoantigens.

Authors:  Alexander V Misharin; Yuji Nagayama; Holly A Aliesky; Basil Rapoport; Sandra M McLachlan
Journal:  Endocrinology       Date:  2009-03-05       Impact factor: 4.736

3.  Statistical analysis of functional region(s) of the TSH receptor.

Authors:  H Sugawa; Y Ueda; T Akamizu; S Kosugi; J Okuda; C Ohta; Y Kiho; T Mori
Journal:  J Endocrinol Invest       Date:  1995-10       Impact factor: 4.256

4.  Cathepsin S is not crucial to TSHR processing and presentation in a murine model of Graves' disease.

Authors:  Mrinalini Kala; Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport; Holly Aliesky; Harold A Chapman
Journal:  Immunology       Date:  2005-12       Impact factor: 7.397

5.  Role of the transgenic human thyrotropin receptor A-subunit in thyroiditis induced by A-subunit immunization and regulatory T cell depletion.

Authors:  Y Mizutori; Y Nagayama; D Flower; A Misharin; H A Aliesky; B Rapoport; S M McLachlan
Journal:  Clin Exp Immunol       Date:  2008-09-22       Impact factor: 4.330

6.  Evidence that factors other than particular thyrotropin receptor T cell epitopes contribute to the development of hyperthyroidism in murine Graves' disease.

Authors:  P N Pichurin; Chun-Rong Chen; Y Nagayama; O Pichurina; B Rapoport; S M McLachlan
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

7.  The superagonistic activity of bovine thyroid-stimulating hormone (TSH) and the human TR1401 TSH analog is determined by specific amino acids in the hinge region of the human TSH receptor.

Authors:  Sandra Mueller; Gunnar Kleinau; Mariusz W Szkudlinski; Holger Jaeschke; Gerd Krause; Ralf Paschke
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

8.  Epitope recognition in HLA-DR3 transgenic mice immunized to TSH-R protein or peptides.

Authors:  Hidefumi Inaba; Leonard Moise; William Martin; Anne S De Groot; Joe Desrosiers; Ryan Tassone; George Buchman; Takashi Akamizu; Leslie J De Groot
Journal:  Endocrinology       Date:  2013-04-16       Impact factor: 4.736

9.  Induction of thyroiditis in mice with thyrotropin receptor lacking serologically dominant regions.

Authors:  S H Wang; G Carayanniotis; Y Zhang; M Gupta; A M McGregor; J P Banga
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

10.  Breaking tolerance in transgenic mice expressing the human TSH receptor A-subunit: thyroiditis, epitope spreading and adjuvant as a 'double edged sword'.

Authors:  Sandra M McLachlan; Holly A Aliesky; Chun-Rong Chen; Gao Chong; Basil Rapoport
Journal:  PLoS One       Date:  2012-09-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.